Swine flu vaccine

In a drive to inoculate people against swine flu before winter, many European governments say they will fast-track the testing of a vaccine, arousing concern among some experts about safety and proper doses.
The European Medicines Agency, the EU's top drug regulatory body, is accelerating the approval process for swine flu vaccine, and countries such as Britain, Greece, France and Sweden say they'll start using the vaccine after it's greenlighted - possibly within weeks.

In an interview with The Associated Press, Dr. Keiji Fukuda, the World Health Organization's flu chief, warned about the potential dangers of untested vaccines, although he stopped short of criticizing Europe's approach outright.
"One of the things which cannot be compromised is the safety of vaccines," he said Friday. "There are certain areas where you can make economies, perhaps, but certain areas where you simply do not try to make any economies."
The WHO's experts are assured; that the pandemic of a swine flu will touch all countries of the world is only a matter of time.
At the same time the first tests of a new vaccine against a swine flu on volunteers have begin in Australia on Wednesday, on July, 22nd. As the representative of Australian pharmaceutical company CSL Ltd informs, 240 volunteers from 18 till 64 years were recruited to testing.

Two injections of a vaccine within three weeks will be given to participants of tests, and then patients will pass regular analyses of blood. So physicians can define whether an organism develops the suitable immune answer to a virus. According to the physicians, specific virus A/H1N1 will demand a double dose of a vaccine, that guarantee the sufficient level of the immune answer with more probability